Ken Griffin Rx Sight, Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Rx Sight, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 18,700 shares of RXST stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,700
Previous 39,900
53.13%
Holding current value
$1.03 Million
Previous $2.06 Million
45.34%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding RXST
# of Institutions
233Shares Held
31.4MCall Options Held
57.8KPut Options Held
12.5K-
Ra Capital Management, L.P. Boston, MA3.69MShares$203 Million3.35% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$132 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.01MShares$110 Million0.0% of portfolio
-
Lord, Abbett & Co. LLC Jersey City, NJ1.74MShares$95.4 Million0.35% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.33MShares$73.3 Million0.13% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $1.52B
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...